Stock Price Quote for TECH

What does Bio-Techne Corp do?

Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the following segments: Protein Sciences and Diagnostics &Genomics. The Protein Sciences segment develops and manufactures purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. This segment also includes protein analysis solutions that offer researchers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. The Diagnostics &Genomics segment develops and manufactures diagnostic products, including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers, as well as a portfolio of clinical molecular diagnostic oncology assays, including the ExoDx Prostate(IntelliScore) test (EPI) for prostate cancer diagnosis. This segment also manufactures and sells advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use. The company was founded on 1976 and is headquartered in Minneapolis, MN. To learn more, visit their official website at bio-techne.com.

Where is Bio-Techne Corp located?

Bio-Techne Corp is headquartered in Minneapolis, Minnesota. Their full address is 614 McKinley Place NE, Minneapolis, Minnesota 55413-2610, United States.

What exchange is Bio-Techne Corp traded on?

Shares for Bio-Techne Corp are traded on the Nasdaq exchange under ticker symbol "TECH".

What industry is Bio-Techne Corp in?

Bio-Techne Corp operates in the Health Care/Life Sciences sector while being primarily involved in the Biotechnology industry.